{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,12]],"date-time":"2024-06-12T13:13:13Z","timestamp":1718197993206},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1097\/mcg.0b013e3181595b40","type":"journal-article","created":{"date-parts":[[2009,1,16]],"date-time":"2009-01-16T08:14:21Z","timestamp":1232093661000},"page":"140-146","source":"Crossref","is-referenced-by-count":11,"title":["Helicobacter pylori Eradication in Patients on Long-term Treatment With NSAIDs Reduces the Severity of Gastritis"],"prefix":"10.1097","volume":"43","author":[{"given":"Helena T.J.I.","family":"De Leest","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsti S.","family":"Steen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Bloemena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Willem F.","family":"Lems","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ernst J.","family":"Kuipers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart A.F.J.","family":"Van de Laar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.W.J.","family":"Bijlsma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthijs","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry H.M.L.","family":"Houben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piet J.","family":"Kostense","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten","family":"Boers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben A.C.","family":"Dijkmans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-8-20210305","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1056\/NEJM199906173402407","article-title":"Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs","volume":"340","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"R2-8-20210305","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1001\/jama.284.10.1247","article-title":"Gastrointestinal toxicity with celecoxib vs. nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study","volume":"284","author":"Silverstein","year":"2000","journal-title":"JAMA"},{"key":"R4-8-20210305","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1056\/NEJM200011233432103","article-title":"Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group","volume":"343","author":"Bombardier","year":"2000","journal-title":"N Engl J Med"},{"key":"R5-8-20210305","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(02)07272-0","article-title":"Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial","volume":"359","author":"Chan","year":"2002","journal-title":"Lancet"},{"key":"R6-8-20210305","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/S0140-6736(98)04206-8","article-title":"Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter Eradication for Lesion Prevention","volume":"352","author":"Hawkey","year":"1998","journal-title":"Lancet"},{"key":"R7-8-20210305","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/gut.51.3.329","article-title":"Primary prevention of diclofenac associated ulcers and dyspepsia by omeprazole or triple therapy in Helicobacter pylori positive patients: a randomised, double blind, placebo controlled, clinical trial","volume":"51","author":"Labenz","year":"2002","journal-title":"Gut"},{"key":"R8-8-20210305","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(84)91816-6","article-title":"Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration","volume":"1","author":"Marshall","year":"1984","journal-title":"Lancet"},{"key":"R9-8-20210305","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1056\/NEJMoa001999","article-title":"Helicobacter pylori infection and the development of gastric cancer","volume":"345","author":"Uemura","year":"2001","journal-title":"N Engl J Med"},{"key":"R10-8-20210305","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1053\/gast.2001.27999","article-title":"Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection","volume":"121","author":"Ekstrom","year":"2001","journal-title":"Gastroenterology"},{"issue":"1","key":"R11-8-20210305","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1046\/j.1365-2036.2002.0160s1034.x","article-title":"Review article: the effect of Helicobacter pylori infection on nonsteroidal anti-inflammatory drug-induced upper gastrointestinal tract injury","volume":"16","author":"Laine","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"R12-8-20210305","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7326\/0003-4819-134-5-200103060-00010","article-title":"Improvement in atrophic gastritis and intestinal metaplasia in patients in whom Helicobacter pylori was eradicated","volume":"134","author":"Ohkusa","year":"2001","journal-title":"Ann Intern Med"},{"key":"R13-8-20210305","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1053\/gast.2000.8550","article-title":"Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study","volume":"119","author":"Sung","year":"2000","journal-title":"Gastroenterology"},{"key":"R14-8-20210305","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0016-5085(97)70076-3","article-title":"Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study","volume":"113","author":"van der Hulst","year":"1997","journal-title":"Gastroenterology"},{"key":"R15-8-20210305","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1136\/gut.46.5.615","article-title":"Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy","volume":"46","author":"Schenk","year":"2000","journal-title":"Gut"},{"key":"R16-8-20210305","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/gut.53.1.12","article-title":"Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial","volume":"53","author":"Kuipers","year":"2004","journal-title":"Gut"},{"key":"R17-8-20210305","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1053\/gast.1999.0029900319","article-title":"Lack of effect of acid suppression therapy on gastric atrophy. Nordic GERD Study Group","volume":"117","author":"Lundell","year":"1999","journal-title":"Gastroenterology"},{"key":"R18-8-20210305","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1136\/gut.2006.101634","article-title":"Current concepts in the management of Helicobacter pylori infection\u2014The Maastricht III Consensus Report","volume":"6","author":"Malfertheiner","year":"2007","journal-title":"Gut"},{"key":"R19-8-20210305","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/00365529850170982","article-title":"Accuracy of seven different tests for the diagnosis of Helicobacter pylori infection and the impact of H2-receptor antagonists on test results","volume":"33","author":"Lerang","year":"1998","journal-title":"Scand J Gastroenterol"},{"key":"R20-8-20210305","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1128\/JCM.35.1.292-294.1997","article-title":"Evaluation of eight enzyme immunoassays for detection of immunoglobulin G against Helicobacter pylori","volume":"35","author":"Meijer","year":"1997","journal-title":"J Clin Microbiol"},{"key":"R21-8-20210305","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1128\/JCM.34.1.94-97.1996","article-title":"Comparison of three commercially available enzyme-linked immunosorbent assays and biopsy-dependent diagnosis for detecting Helicobacter pylori infection","volume":"34","author":"van de Wouw","year":"1996","journal-title":"J Clin Microbiol"},{"key":"R22-8-20210305","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/j.1523-5378.2007.00543.x","article-title":"Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID-treatment: double-blind, randomized, placebo-controlled trial","volume":"5","author":"de Leest","year":"2007","journal-title":"Helicobacter"},{"key":"R23-8-20210305","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","article-title":"Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994","volume":"20","author":"Dixon","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"R24-8-20210305","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1023\/A:1013251100950","article-title":"NSAID gastric ulceration: predictive value of gastric pH, mucosal density of polymorphonuclear leukocytes, or levels of IL-8 or nitrite","volume":"47","author":"Shiotani","year":"2002","journal-title":"Dig Dis Sci"},{"key":"R25-8-20210305","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1136\/gut.34.12.1677","article-title":"Prevalence of Helicobacter pylori infection and its effect on symptoms and non-steroidal anti-inflammatory drug induced gastrointestinal damage in patients with rheumatoid arthritis","volume":"34","author":"Goggin","year":"1993","journal-title":"Gut"},{"key":"R26-8-20210305","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1136\/jcp.54.7.521","article-title":"The histopathology of non-steroidal anti-inflammatory drug induced gastroduodenal damage: correlation with Helicobacter pylori, ulcers, and haemorrhagic events","volume":"54","author":"Frezza","year":"2001","journal-title":"J Clin Pathol"},{"key":"R27-8-20210305","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0016-5085(99)70120-4","article-title":"Neutrophils, Helicobacter pylori, and nonsteroidal anti-inflammatory drug ulcers","volume":"116","author":"Taha","year":"1999","journal-title":"Gastroenterology"},{"key":"R28-8-20210305","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/S0140-6736(95)91084-0","article-title":"Long-term sequelae of Helicobacter pylori gastritis","volume":"345","author":"Kuipers","year":"1995","journal-title":"Lancet"},{"key":"R29-8-20210305","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/gut.36.1.12","article-title":"Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole","volume":"36","author":"Logan","year":"1995","journal-title":"Gut"},{"key":"R30-8-20210305","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJM199604183341603","article-title":"Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication","volume":"334","author":"Kuipers","year":"1996","journal-title":"N Engl J Med"},{"key":"R31-8-20210305","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1016\/S0002-9270(01)02804-0","article-title":"Quantitative assessment of gastric corpus atrophy in subjects using omeprazole: a randomized follow-up study","volume":"96","author":"van Grieken","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"R32-8-20210305","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1159\/000076544","article-title":"Quantitative assessment of gastric antrum atrophy shows restitution to normal histology after Helicobacter pylori eradication","volume":"69","author":"van Grieken","year":"2004","journal-title":"Digestion"},{"key":"R33-8-20210305","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1136\/jcp.39.5.524","article-title":"Reflux gastritis: distinct histopathological entity?","volume":"39","author":"Dixon","year":"1986","journal-title":"J Clin Pathol"},{"key":"R34-8-20210305","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/S0046-8177(96)90349-4","article-title":"Histological features do not define NSAID-induced gastritis","volume":"27","author":"El Zimaity","year":"1996","journal-title":"Hum Pathol"}],"container-title":["Journal of Clinical Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00004836-200902000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:20:28Z","timestamp":1618035628000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00004836-200902000-00008"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/mcg.0b013e3181595b40","relation":{},"ISSN":["0192-0790"],"issn-type":[{"value":"0192-0790","type":"print"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}